Celltrion

8 Minutes
Celltrion

BioBlast w/e 26 May 23

26 MAY 2023 | EU | Celltrion files MAA with EMA for biosimilar to Janssen’s Stelara® (ustekinumab) Korea Biomed has reported that Celltrion filed a marketing authorisation application with the EMA for CT-P43, its biosimilar to Janssen’s Stelara® (ustekinemab).  Based...
Read More